Biorigen

Biorigen is a pioneering Brazilian biotechnology company dedicated to the development of regenerative medicine and advanced cell therapies. Founded in 2005 and based in Salvador, the company focuses on translating stem cell research into clinical treatments for high-burden diseases, particularly cardiovascular conditions like Chagasic cardiomyopathy and chronic heart failure. Biorigen was the first entity in Brazil to obtain regulatory approval from ANVISA for cell therapy clinical trials, establishing itself as a leader in the Latin American biotech landscape. The company maintains strong ties with academic and medical institutions, such as FIOCRUZ and Hospital São Rafael, to advance its pipeline of autologous and allogeneic cell-based products. Its mission is to provide innovative biological solutions for conditions with limited therapeutic options.